A comparative study of a long acting luteinizing hormone releasing hormone agonist (Decapeptyl) and orchiectomy in the treatment of advanced prostatic cancer. Preliminary report.
作者信息
De Sy W A, de Meyer J M, Casselman J, De Smet R, Renders G, Schelfhout W, De Wilde P
出版信息
Acta Urol Belg. 1986;54(2):221-9.
PMID:2942015
Abstract
摘要
相似文献
1
2
Long term experience in the treatment of advanced prostatic cancer with decapeptyl, compared to orchiectomy.
Acta Urol Belg. 1988;56(4):581-8.
3
Decapeptyl in the treatment of advanced prostatic cancer: comparative study with pulpectomy.
Prog Clin Biol Res. 1989;303:53-60.
4
Decapeptyl in the treatment of metastatic prostatic cancer. Comparative study with pulpectomy.
Prog Clin Biol Res. 1987;243A:199-206.
5
Metastatic prostate cancer under long term pernasal buserelin or intramuscular decapeptyl depot treatment.
Prog Clin Biol Res. 1987;243A:207-20.
6
Induction and maintenance of castration by an LHRH analogue: D-Trp6 LHRH or decapeptyl.
Prog Clin Biol Res. 1987;243A:245-7.
7
[Treatment of prostatic cancer].
J Urol (Paris). 1984;90(10):619-48.
8
Leuprolide: a review of its effects in comparison with diethylstilboestrol in the treatment of advanced cancer of the prostate.
Br J Clin Pract Suppl. 1985 Mar;37:8-12, 20-4.
9
Effect of surgical and biochemical castration and an antiandrogen on patients with stage D2 prostatic cancer: preliminary results.
Prog Clin Biol Res. 1987;243A:439-43.
引用本文的文献
1
A phase II trial with new triptorelin sustained release formulations in prostatic carcinoma.一项关于新型曲普瑞林缓释制剂治疗前列腺癌的II期试验。
Int Urol Nephrol. 2001;33(2):379-83. doi: 10.1023/a:1015274031704.
Zotero 插件